Rhenman & Partners Asset Management Ab Mirum Pharmaceuticals, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 73,755 shares of MIRM stock, worth $3.72 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
73,755
Previous 73,755
-0.0%
Holding current value
$3.72 Million
Previous $3.05 Million
8.95%
% of portfolio
0.4%
Previous 0.32%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$343 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$240 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$163 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$141 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$128 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.85B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...